You are here

Article Text

Article menu
Download PDFPDF
Rare disease
CASE REPORT
Dandy-Walker variant with precocious puberty: a rare association
  1. Rajesh Rajput1,
  2. Sanat Mishra2,
  3. Parul Ahlawat2 and
  4. Pawan Kumar Yadav3
  1. 1 Department of Endocrinology and Medicine Unit, Pt. B D Sharma Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India
  2. 2 Department of Endocrinology and Medicine Unit, Pt. B D Sharma Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India
  3. 3 Department of Medicine, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India
  1. Correspondence to Dr Rajesh Rajput, drrajeshrajput{at}outlook.com

Abstract

Precocious puberty is characterised by premature appearance of secondary sexual characteristics before the age of 7 years in girls and 9 years in boys. Dandy-Walker malformation comprises a spectrum of intracranial malformations of the posterior fossa. We present a case of a 7-year-old male child who has presented with features of central precocious puberty and on further evaluation has been found to have Dandy-Walker variant and secondary hypothyroidism. The following case report describes this association which is extremely rare and has never been described in literature.

  • endocrine system
  • thyroid disease
  • neurology

http://dx.doi.org/10.1136/bcr-2018-226281

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors RR conceived the idea of the case report. PA and PKY have worked on the investigation, collection and interpretation of data. SM has helped with the reporting of the manuscript.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent Obtained.

    • Provenance and peer review Not commissioned; externally peer reviewed.